Abstract:Background: Graves' disease (GD) patients experience two major issues: one is the severe hyperthyroidism associated with newly diagnosed GD, and the other involves the disfiguring and dysfunctional features of active Graves' orbittipathy (GO). Therefore, the aim of our study was to identify potential markers involved in the initial phase of GD dysfunction and the development of active GO. Methods: Seventy-eight subjects were recruited: 40 with newly diagnosed GD, 20 with inactive GO and 18 with active GO. GO activity was evaluated by the clinical activity score (CAS, active GO = CAS >= 3), and severity was assessed according to the NOSPECS classification. Plasma selenium concentrations were determined by dual channel hydride generation atomic fluorescence photometry. A liquid chip assay was used to measure plasma Th1 cytokines IFN-gamma and TNF-alpha; Th2 cytokines IL4, IL5 and IL6; Th17 cytokine IL23; Treg cytokines IL10 and TGF-beta; and two chemokines, CCL2 (Th2 chemokine) and CXCL10 (Th1 chemokine). Results: Among the three groups, newly diagnosed GD patients showed significantly elevated plasma levels of CXCL10 and IL-23 (all p < 0.05). Both CXCL10 and IL23 were significantly correlated with hyperthyroidism severity, specifically, increasing FT3 and FT4 and decreasing TSH. Notably, a very strong positive relationship between IL23 and CXCL10 was revealed (adjusted R square = 0.795; p < 0.001). Moreover, the selenium level was lower, while that of CCL2 was higher, in active GO than in inactive GO (p = 0.007, p < 0.001, respectively). Likewise, we also discovered that increasing CCL2 levels and decreasing selenium levels were associated with high CAS. Remarkably, after adjusting for potential confounding factors, selenium (OR, 0.919) and CCL2 (OR, 1.042) were still independent predictors for the diagnosis of active GO, and similar conclusions were drawn by receiver operating characteristic (ROC) curve analysis. Conclusion: Pro-inflammatory cytokines, especially Th17-associated cytokines (e.g., IL23) and Thl chemokines (e.g., CXCL10), appear to be involved in the initial phase of GD dysfunction. Moreover, we revealed for the first time that decreased plasma selenium levels and increased concentrations of Th2 chemokines (e.g., CCL2) may reflect GO disease activity, shedding light on the diagnosis and evaluation of active GO.

Serum interferon levels associated with the disease activity in women with overt Graves' disease

Impairment of Regulatory Capacity of Cd4(+)Cd25(+) Regulatory T Cells Mediated by Dendritic Cell Polarization and Hyperthyroidism in Graves' Disease

Expression of IFNα-inducible Genes and Modulation of HLA-DR and Thyroid Stimulating Hormone Receptors in Graves’ Disease

Interleukin-21 is Associated with Disease Activity in Patients with Graves’ Disease

Elevated Interleukin-36α and CD4+IL-36α+T Cells Are Involved in the Pathogenesis of Graves' Disease.

Constitutive Changes in Circulating Follicular Helper T Cells and Their Subsets in Patients with Graves’ Disease

A High Frequency Of Circulating Th22 And Th17 Cells In Patients With New Onset Graves' Disease

Differential Cytokine Expression Detected by Protein Microarray Screening in Peripheral Blood of Patients with Refractory Graves' Disease.

Increased Human Interleukin-32 Expression is Related to Disease Activity of Graves' Disease.

Characterization and Clinical Relevance of Circulating CD4+CD28− T Cells in Graves’ Disease

Th1, Th2, and Th17 Cytokine Involvement in Thyroid Associated Ophthalmopathy

Increased YKL-40 Levels Are Linked with Disease Severity of Initially Diagnosed Graves’ Disease

Serum Interleukin Profile in Patients with Graves Orbithopathy

Association Of Graves' Disease And Prevalence Of Circulating Ifn-Gamma-Producing Cd28(-) T Cells

The Potential Markers Involved in Newly Diagnosed Graves' Disease and the Development of Active Graves' Orbitopathy.

Expression levels and genetic polymorphisms of interleukin-2 and interleukin-10 as biomarkers of Graves’ disease

Elevated Follicular Helper T Cells and Expression of IL-21 in Thyroid Tissues Are Involved in the Pathogenesis of Graves' Disease.

The Role of Circulating CD4+ CD28- T Cell in the Development of Graves' Disease

Plasmacytoid dendritic cells,interferon-α and CD4~+ CD25~+ regulatory T cells in immunopathogenic mechanism of Graves disease

Increased chemokine (C–C motif) ligand 21 expression and its correlation with osteopontin in Graves’ disease

Correction Between Cytokine Expressions in Circulating CD4~+ CD28~-T Cells and Graves'ophthalmopathy